The Quintuple Aim: A New Direction for Healthcare Improvement

By Michael Awood

October 26, 2023

The healthcare industry has faced significant challenges recently which has led to escalating costs. These have also continued to expand the disparities within healthcare worldwide. The COVID-19 pandemic brought these to light, with the marginalised communities experiencing higher rates of infection, morbidity, and mortality. These communities also continued to experience greater care disruptions. But what can be done about this? How could technology look to improve the outcomes and provide value? The quintuple framework proposes valuable aspects to improve healthcare systems and coupled with this, AI technologies can look to scale these improvements.

 

The Quintuple Aim

The need to optimise healthcare outcomes and reduce economic waste is more critical than ever. The triple aim was introduced as a beacon to guide healthcare improvements, focusing on enhancing population health, improving care experience, and promoting cost efficiency. However, the rising burnout rates among physicians and the increasing desire to leave the industry necessitated the inclusion of a fourth aim: addressing provider well-being. Without this, quality improvements would be unsustainable. The fifth aim was updated to include health equity, which ensures that we explicitly address equity and actively explore new efforts to promote it.

The quintuple aims for healthcare improvement are:

  1. Improving population health
  2. Enhancing care experience
  3. Cost Efficiency
  4. Provider Wellbeing
  5. Health Equity

 

The Role of Technology and Policy

Technology, particularly AI, plays a crucial role in achieving these aims. AI can improve access to equitable health, ensure cost-effectiveness through predictive algorithms, and manage procedural or administrative work through virtual assistants. Oracle Health has recently shown its new work in the healthcare space and optimising clinical models through the use of LMMs (multimodal models), by launching their digital assistant. The view is that it reduces the cognitive load on clinicians optimising the clinical delivery process, which ultimately also keeps it human. In turn, improvements to patient safety (increased clinician awareness), experience, and provider well-being are immediately actualised. These in turn allow for the other aims to occur as a direct outcome of these enhancements.

Policies based on these principles are essential for designing effective economic supports. Through explainable AI systems, value-based care incentives, and appropriate demographic data, outcomes can be improved, and care can be enhanced in any resource setting.

 

Cover image taken from: Chess Health Solutions

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.